Earnings summaries and quarterly performance for METLIFE.
Executive leadership at METLIFE.
Michel A. Khalaf
Detailed
President and Chief Executive Officer
CEO
AO
Adrienne O'Neill
Detailed
Executive Vice President and Chief Accounting Officer
BP
Bill Pappas
Detailed
Executive Vice President and Head of Global Technology and Operations
EC
Eric Clurfain
Detailed
Regional President, Latin America
JD
John D. McCallion
Detailed
Executive Vice President and Chief Financial Officer
LO
Lyndon Oliver
Detailed
Regional President, Asia
MD
Marlene Debel
Detailed
Executive Vice President and Chief Risk Officer
MR
Michael Roberts
Detailed
Executive Vice President and Chief Marketing Officer
MC
Monica Curtis
Detailed
Executive Vice President and Chief Legal Officer
NG
Nuria Garcia
Detailed
Regional President, EMEA
RT
Ramy Tadros
Detailed
Regional President, U.S. Business and Head of MetLife Holdings
SS
Shurawl Sibblies
Detailed
Executive Vice President and Chief Human Resources Officer
Board of directors at METLIFE.
CA
Carla A. Harris
Detailed
Director
CM
Carlos M. Gutierrez
Detailed
Director
CM
Christian Mumenthaler
Detailed
Director
DM
Denise M. Morrison
Detailed
Director
DL
Diana L. McKenzie
Detailed
Director
JC
Jeh C. Johnson
Detailed
Director
LJ
Laura J. Hay
Detailed
Director
MA
Mark A. Weinberger
Detailed
Director
RG
R. Glenn Hubbard
Detailed
Chairman of the Board
WE
William E. Kennard
Detailed
Director
Research analysts who have asked questions during METLIFE earnings calls.
Suneet Kamath
Jefferies
8 questions for MET
Also covers: AFL, AMP, BHF +12 more
WC
Wesley Carmichael
Autonomous Research
8 questions for MET
Also covers: ACGL, AFL, BHF +16 more
Joel Hurwitz
Dowling & Partners Securities, LLC
7 questions for MET
Also covers: AFL, CNO, CRBG +9 more
Ryan Krueger
KBW
7 questions for MET
Also covers: AFL, AMP, ASGN +14 more
TG
Thomas Gallagher
Evercore
7 questions for MET
Also covers: AFL, AMP, BHF +13 more
Alex Scott
Barclays PLC
5 questions for MET
Also covers: ACGL, AFL, AIG +30 more
JB
Jimmy Bhullar
JPMorgan Chase & Co.
4 questions for MET
Also covers: ACGL, AFL, ALL +12 more
EG
Elyse Greenspan
Wells Fargo
3 questions for MET
Also covers: ACGL, AFL, AHL +32 more
JB
Jamminder Bhullar
JPMorgan Chase & Co.
3 questions for MET
Also covers: ACGL, AFL, ALL +13 more
CM
Cave Montazeri
Deutsche Bank
2 questions for MET
Also covers: ACGL, AHL, AJG +5 more
TG
Tom Gallagher
Evercore ISI
2 questions for MET
Also covers: AMP, CRBG, EQH +6 more
Wilma Burdis
Raymond James Financial
2 questions for MET
Also covers: AFL, ALTI, AMP +18 more
Wilma Jackson Burdis
Raymond James
2 questions for MET
Also covers: AFL, ALTI, AMP +12 more
JB
John Barnidge
Piper Sandler
1 question for MET
Also covers: AFL, AIZ, AMP +17 more
NA
Nick Anido
Wells Fargo & Company
1 question for MET
Also covers: LNC
Recent press releases and 8-K filings for MET.
MetLife issues $1 billion subordinated debentures due 2056
MET
Debt Issuance
- $1.0 billion 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due March 15, 2056 issued at 100.000% of par.
- Settlement on February 26, 2026 (T+2) with $990 million net proceeds after 1.000% underwriting discount.
- Interest resets on March 15, 2036 and every five years thereafter at the five-year Treasury rate + 1.817%, with semiannual payments and an optional deferral feature of up to five years per period.
- Debt ranks subordinated unsecured, junior to senior indebtedness and pari passu with MetLife’s 6.350% fixed-to-fixed reset subordinated debentures due 2055.
6 days ago
MetLife outlines New Frontier strategy execution at BoA conference
MET
Guidance Update
M&A
- MetLife’s New Frontier strategy delivered $10 billion in free cash flow for 2025 and shaved 40 bps off direct expenses, while maintaining targets of double-digit EPS growth, 15–17% ROE, and reducing the expense ratio to 11.3% by the end of the plan.
- MetLife Investment Management closed the PineBridge acquisition on December 30, 2025, boosting AUM from $600 billion to over $740 billion and targeting $240–280 million in EBITDA synergies through expanded CLO, multi-asset and alternative capabilities.
- In group benefits, early persistency actions led to strong 1-to-1 renewals, and leave & absence solutions now average 4–5 products bundled per sale, supporting growth within the 4–7% annual target range.
- MetLife reported a record $14 billion in PRT transactions for 2025 with returns aligned to enterprise targets, achieved 17% growth in Japan’s third-sector market, and maintained LATAM momentum toward $1 billion in earnings.
Feb 10, 2026, 2:40 PM
MetLife details 2025 strategy achievements and PineBridge acquisition
MET
M&A
Guidance Update
- Under New Frontier, MetLife delivered 10% EPS growth, strong free cash flow and 40 bps reduction in its direct expense ratio in 2025.
- Group Benefits growth was driven by leave and absence enhancements—with 4–5 products bundled per sale—and improved persistency, underpinning a 4–7% medium-term growth target.
- MetLife Investment Management closed the PineBridge acquisition on December 30, 2025, boosting AUM from ~$600 bn to $740 bn+ and generating $22 bn of net flows.
- Retirement solutions achieved 17% Third Sector growth in Japan and completed record $14 bn in PRT transactions, while leveraging reinsurance deals to support origination platforms.
- International markets—including Mexico, Brazil, Japan and Korea—sustained mid-to-high single-digit growth via diversified, U.S. dollar-denominated products.
Feb 10, 2026, 2:40 PM
MetLife outlines strategic progress and investment management update
MET
Guidance Update
M&A
- MetLife’s New Frontier strategy delivered $10 billion in free cash flow and cut direct expenses by 40 bps in 2025, supporting efficiency and growth in group benefits, asset management, and international markets.
- The company set a double-digit EPS growth target, underpinned by a 60/40 split between earnings growth and capital management, while shrinking its legacy retail runoff business.
- MetLife reaffirmed its 15–17% ROE goal, driven by high-ROE new business returns and efficiency gains; it reduced its expense ratio to 11.7% in 2025 and targets 11.3% by year-end.
- MetLife completed the PineBridge acquisition on Dec 30, raising AUM to $740 billion+ with $22 billion net inflows, and forecast $240–280 million of EBITDA growth in 2026 from revenue synergies.
- In international markets, MetLife recorded 17% growth in Japan’s third sector, strong momentum in Mexico and Brazil despite VAT headwinds, and is on track toward a $1 billion earnings goal in Latin America.
Feb 10, 2026, 2:40 PM
MetLife reports Q4 2025 results
MET
Earnings
Guidance Update
Share Buyback
- Adjusted EPS of $2.58 ex-notable items in Q4 (up 24% y/y) on $1.6 billion of adjusted earnings; full-year 2025 adjusted EPS was $8.89 (+10% y/y) on $6.0 billion of adjusted earnings ex-notables.
- Adjusted premiums, fees & other revenues (PFOs) rose 8% to $12.8 billion in Q4 (29% to $18.6 billion including PRT); segment Q4 adjusted earnings were Group Benefits $465 million (+12%), RIS $454 million (+18%), Asia $444 million (+1% cc), Latin America $227 million (+13%), EMEA $97 million (+64%).
- Strong capital management with $3.6 billion of holding-company liquidity at year-end, retirement of $500 million debt, $430 million of share buybacks and $370 million of dividends in Q4, plus an additional $200 million repurchased in January.
- 2026 outlook targets: double-digit adjusted EPS growth, 15%–17% ROE, 65%–75% two-year average free cash flow ratio, 12.1% direct expense ratio and $1.6 billion of pre-tax variable investment income.
Feb 5, 2026, 2:00 PM
MetLife reports Q4 2025 results and outlines 2026 guidance
MET
Earnings
Guidance Update
- Adjusted EPS of $2.49 and $2.58 ex-notables, up 24% YoY, with $1.6 billion in adjusted earnings in Q4 2025.
- Full-year 2025 adjusted EPS of $8.89, up ~10%, with 16% adjusted ROE and 11.7% direct expense ratio—both ahead of targets.
- PFOs rose 8% to $12.8 billion in Q4 (29% including retained PRT), driven by robust volume growth across businesses.
- Q4 segment adjusted earnings: Group Benefits $465 million, Retirement & Income Solutions $454 million, Asia $444 million, Latin America $227 million, EMEA $97 million, and MetLife Investment Management $60 million.
- 2026 guidance includes double-digit adjusted EPS growth, 15%–17% ROE, a 65%–75% free cash flow ratio, ~12.1% direct expense ratio, and ~$1.6 billion pre-tax variable investment income.
Feb 5, 2026, 2:00 PM
MetLife reports Q4 2025 results
MET
Earnings
- MetLife delivered 10% adjusted EPS growth and achieved an adjusted ROE of 16.0% in FY25, surpassing targets, with FY25 adjusted EPS of $8.83 per share.
- Q4 2025 adjusted earnings excluding notable items rose 18% YoY to $1,709 million ( $2.58 per share), driven by underwriting and investment margin expansion across core segments.
- FY25 free cash flow ratio reached 81%, above the 65–75% target; direct expense ratio improved to 11.7%, beating the 12.1% goal.
- Q4 variable investment income was $393 million (pre-tax), including $497 million from private equity, contributing to $1.187 billion VII for FY25 (post-tax).
- Segment adjusted earnings ex-notable items in Q4: Group Benefits +12% to $465 million; Retirement & Income Solutions +18% to $454 million; EMEA +64% to $97 million; MetLife Investment Management +275% to $60 million.
Feb 5, 2026, 2:00 PM
MetLife reports Q4 2025 earnings and provides 2026 guidance
MET
Earnings
Guidance Update
Share Buyback
- Q4 adjusted EPS of $2.58, up 24% year-over-year, and full-year adjusted EPS of $8.89, up roughly 10%; 2025 adjusted ROE was 16% (target 15%-17%) and direct expense ratio improved to 11.7% (target 11.3%).
- Q4 adjusted earnings by segment: Group Benefits $465 M, Retirement & Income Solutions $454 M, Asia $444 M, Latin America $227 M, EMEA $97 M, MetLife Investment Management $60 M; 2024-25 two-year average free cash flow ratio was 81% (target 65%-75%).
- In 2025 MetLife returned ~$4.4 B to shareholders (common repurchases $2.9 B, dividends $1.5 B), funded $1.2 B of acquisitions including PineBridge, and ended Q4 with $3.6 B of holding company liquidity; 2026 repurchases expected in line with 2025.
- 2026 outlook: double-digit adjusted EPS growth, adjusted ROE 15%-17%, direct expense ratio ~12.1%, pre-tax variable investment income ~$1.6 B; segment forecasts include Group Benefits earnings growth of 7%-9%, RIS earnings of $1.6 B–$1.8 B, and MIM adjusted earnings of $240 M–$280 M.
Feb 5, 2026, 2:00 PM
MetLife announces full year and Q4 2025 results
MET
Earnings
- Full-year 2025 net income of $3.2 billion (or $4.71 per share); adjusted EPS (ex-items) up 10% to $8.89; PFOs up 10% to $57.6 billion (adjusted PFOs ex-PRT +5% to $49.8 billion)
- Q4 2025 net income of $778 million (or $1.17 per share); adjusted EPS (ex-items) +24% to $2.58; PFOs +29% to $18.7 billion (adjusted PFOs ex-PRT +8% to $12.8 billion)
- Book value per share rose 14% to $39.02 (adjusted +4% to $57.07); returned $4.4 billion to shareholders; holding company cash/liquid assets of $3.6 billion at year-end
- Net investment income up 10% to $5.9 billion in Q4, including $497 million of variable investment income
Feb 4, 2026, 10:07 PM
MetLife reports full year and 4Q 2025 results
MET
Earnings
- $3.2 billion net income for 2025 (EPS $4.71) and 10% adjusted EPS growth to $8.89.
- Q4 net income of $778 million (EPS $1.17) with 24% adjusted EPS growth to $2.58; PFOs up 29% to $18.7 billion (adjusted PFOs excluding PRT up 8% to $12.8 billion).
- 2025 PFOs rose 10% to $57.6 billion (adjusted PFOs excluding PRT up 5% to $49.8 billion).
- Full year ROE of 12.9% (adjusted ROE 16%); Q4 ROE 12.0% (adjusted ROE 17.6%).
- Returned nearly $4.4 billion to shareholders; holding company cash of $3.6 billion at year end.
Feb 4, 2026, 9:15 PM
Fintool News
In-depth analysis and coverage of METLIFE.
Quarterly earnings call transcripts for METLIFE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more